CellWell record HH-157379
Modulation of Inflammatory Indices by Omega-3 Fatty Acids Supplementation in Hemodialysis: A Clinical Trial Approach
Hanieh Shafaei Kachaei; Khadijeh Abbasi Mobarakrh; Fatemeh Azaryan; Mahdieh Torkaman; Seyed Ali Askarpour; Asma Rajabi Harsini; Fatemeh Sadat Fahimzad; Mahdi Mousavi Mele; Marziyeh Hoseinzadeh Liavoli; Neda Masoomi Golujeh; Sanaz Ataie Kashki; Sara Khoshdooz; Saeid Doaei; Masoud Khosravi; Maryam Gholamalizadeh
2026
In plain language
Two-month omega-3 supplementation did not significantly reduce C-reactive protein or interleukin-6 levels in hemodialysis patients compared to placebo.
- Evidence
- Established
- Design
- Randomized controlled trial
Cite this record: https://thecellwell.org/studies/HH-157379
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.